IBDEI0CV ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5896,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5896,1,3,0)
 ;;=3^Systemic Sclerosis NEC
 ;;^UTILITY(U,$J,358.3,5896,1,4,0)
 ;;=4^M34.89
 ;;^UTILITY(U,$J,358.3,5896,2)
 ;;=^5011784
 ;;^UTILITY(U,$J,358.3,5897,0)
 ;;=M34.9^^30^385^278
 ;;^UTILITY(U,$J,358.3,5897,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5897,1,3,0)
 ;;=3^Systemic Sclerosis,Unspec
 ;;^UTILITY(U,$J,358.3,5897,1,4,0)
 ;;=4^M34.9
 ;;^UTILITY(U,$J,358.3,5897,2)
 ;;=^5011785
 ;;^UTILITY(U,$J,358.3,5898,0)
 ;;=R21.^^30^385^257
 ;;^UTILITY(U,$J,358.3,5898,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5898,1,3,0)
 ;;=3^Rash/Nonspecific Skin Eruption
 ;;^UTILITY(U,$J,358.3,5898,1,4,0)
 ;;=4^R21.
 ;;^UTILITY(U,$J,358.3,5898,2)
 ;;=^5019283
 ;;^UTILITY(U,$J,358.3,5899,0)
 ;;=R23.3^^30^385^269
 ;;^UTILITY(U,$J,358.3,5899,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5899,1,3,0)
 ;;=3^Spontaneous Ecchymoses
 ;;^UTILITY(U,$J,358.3,5899,1,4,0)
 ;;=4^R23.3
 ;;^UTILITY(U,$J,358.3,5899,2)
 ;;=^5019295
 ;;^UTILITY(U,$J,358.3,5900,0)
 ;;=L03.113^^30^385^112
 ;;^UTILITY(U,$J,358.3,5900,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5900,1,3,0)
 ;;=3^Cellulitis of Right Upper Limb
 ;;^UTILITY(U,$J,358.3,5900,1,4,0)
 ;;=4^L03.113
 ;;^UTILITY(U,$J,358.3,5900,2)
 ;;=^5009033
 ;;^UTILITY(U,$J,358.3,5901,0)
 ;;=L03.114^^30^385^105
 ;;^UTILITY(U,$J,358.3,5901,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5901,1,3,0)
 ;;=3^Cellulitis of Left Upper Limb
 ;;^UTILITY(U,$J,358.3,5901,1,4,0)
 ;;=4^L03.114
 ;;^UTILITY(U,$J,358.3,5901,2)
 ;;=^5009034
 ;;^UTILITY(U,$J,358.3,5902,0)
 ;;=L03.115^^30^385^109
 ;;^UTILITY(U,$J,358.3,5902,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5902,1,3,0)
 ;;=3^Cellulitis of Right Lower Limb
 ;;^UTILITY(U,$J,358.3,5902,1,4,0)
 ;;=4^L03.115
 ;;^UTILITY(U,$J,358.3,5902,2)
 ;;=^5009035
 ;;^UTILITY(U,$J,358.3,5903,0)
 ;;=L03.116^^30^385^102
 ;;^UTILITY(U,$J,358.3,5903,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5903,1,3,0)
 ;;=3^Cellulitis of Left Lower Limb
 ;;^UTILITY(U,$J,358.3,5903,1,4,0)
 ;;=4^L03.116
 ;;^UTILITY(U,$J,358.3,5903,2)
 ;;=^5133645
 ;;^UTILITY(U,$J,358.3,5904,0)
 ;;=L03.123^^30^385^27
 ;;^UTILITY(U,$J,358.3,5904,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5904,1,3,0)
 ;;=3^Acute Lymphangitis of Right Upper Limb
 ;;^UTILITY(U,$J,358.3,5904,1,4,0)
 ;;=4^L03.123
 ;;^UTILITY(U,$J,358.3,5904,2)
 ;;=^5009039
 ;;^UTILITY(U,$J,358.3,5905,0)
 ;;=L03.124^^30^385^21
 ;;^UTILITY(U,$J,358.3,5905,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5905,1,3,0)
 ;;=3^Acute Lymphangitis of Left Upper Limb
 ;;^UTILITY(U,$J,358.3,5905,1,4,0)
 ;;=4^L03.124
 ;;^UTILITY(U,$J,358.3,5905,2)
 ;;=^5009040
 ;;^UTILITY(U,$J,358.3,5906,0)
 ;;=L03.125^^30^385^25
 ;;^UTILITY(U,$J,358.3,5906,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5906,1,3,0)
 ;;=3^Acute Lymphangitis of Right Lower Limb
 ;;^UTILITY(U,$J,358.3,5906,1,4,0)
 ;;=4^L03.125
 ;;^UTILITY(U,$J,358.3,5906,2)
 ;;=^5009041
 ;;^UTILITY(U,$J,358.3,5907,0)
 ;;=L03.126^^30^385^19
 ;;^UTILITY(U,$J,358.3,5907,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5907,1,3,0)
 ;;=3^Acute Lymphangitis of Left Lower Limb
 ;;^UTILITY(U,$J,358.3,5907,1,4,0)
 ;;=4^L03.126
 ;;^UTILITY(U,$J,358.3,5907,2)
 ;;=^5133646
 ;;^UTILITY(U,$J,358.3,5908,0)
 ;;=L03.211^^30^385^99
 ;;^UTILITY(U,$J,358.3,5908,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5908,1,3,0)
 ;;=3^Cellulitis of Face
 ;;^UTILITY(U,$J,358.3,5908,1,4,0)
 ;;=4^L03.211
 ;;^UTILITY(U,$J,358.3,5908,2)
 ;;=^5009043
 ;;^UTILITY(U,$J,358.3,5909,0)
 ;;=L03.212^^30^385^16
 ;;^UTILITY(U,$J,358.3,5909,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5909,1,3,0)
 ;;=3^Acute Lymphangitis of Face
